The Times has this sobering assessment of the distortion in priorities caused by the war in Iraq.Â
It is routine for pharmaceutical companies to claim a huge amount, as much as $400,000,000, as the opportunity cost of investing in a new drug’s development and simply add that to the real cost. While I question the validity of such an assumption when documenting the actual cost of a commercial product, should we, as a society, do the same with this war. It’s 1.2 trillion dollar cost, does affect our other priorities and of course, adds to the national debt. Is the real cost 2.4 trillion?
Medicynic 